The 20 Best Lung Cancer Doctors Near Me in Bronx, NY

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic & Vascular Surgery at Montefiore Einstein, and the Associate Director for Surgical Services in the Montefiore Einstein Cancer Center. Dr. Stiles’ clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.“The recruitment of Dr. Stiles elevates the treatment of lung cancer to a historic level,” said Robert E. Michler, MD, Surgeon-in-Chief and Chairman and Professor, Department of Surgery and Department of Cardiothoracic & Vascular Surgery at Montefiore-Einstein. “Every thoracic surgical therapy available anywhere in the world will now be offered by Dr. Stiles at Montefiore-Einstein.”After earning his Bachelor of Arts in 1994 at the University of Virginia, Dr. Stiles continued at UVA, earning his Doctor of Medicine in 1999.  He conducted his training in general surgery at the University of Virginia Health System. From 2001 to 2003, Dr. Stiles served as a surgical research fellow at Memorial Sloan-Kettering Cancer Center before returning to the University of Virginia Health System to complete his surgical residency. Dr. Stiles completed a cardiothoracic surgery residency at NewYork-Presbyterian Hospital-Weill Cornell and Memorial Sloan-Kettering Cancer Center in 2008. Dr. Stiles joined the faculty at NewYork-Presbyterian Hospital-Weill Cornell before being recruited by Dr. Michler to Montefiore-Einstein in 2021. Dr. Stiles is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Lymphadenectomy, and Thymectomy. Dr. Stiles is board certified in American Board Of Thoracic Surgery.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Salpingo-Oophorectomy. Dr. Shu is board certified in Internal Medicine and Medical Oncology. Dr. Shu is currently accepting new patients.

Dr. Kalnicki focuses on researching and implementing new technologies in the radiation treatment of cancer, with the aim of enhancing the dose to the tumor target while preserving normal tissues from radiation injury, potentially increasing tumor control and improving quality of life. He pioneered the use of intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT (positron emission tomography – CAT scan) fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. Dr. Kalnicki is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Anal Cancer, Cervical Cancer, and Prostatectomy. Dr. Kalnicki is board certified in American Board Of Radiology, Inc..

Haiying Cheng is an Oncologist practicing medicine in Bronx, New York. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

Raja Flores is a Thoracic Surgeon practicing medicine in New York, New York. Dr. Flores is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Thymectomy.

Kenneth Rosenzweig is a Radiation Oncologist practicing medicine in New York, New York. Dr. Rosenzweig is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Jamie Chaft is an Oncologist practicing medicine in New York, New York. Dr. Chaft is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Chaft is currently accepting new patients.

Gregory Riely is an Oncologist practicing medicine in New York, New York. Dr. Riely is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Thymic Epithelial Tumor, Tissue Biopsy, and Liver Embolization. Dr. Riely is currently accepting new patients.

Helena Yu is an Oncologist practicing medicine in New York, New York. Dr. Yu is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Yu is currently accepting new patients.

Jarushka Naidoo is an Oncologist practicing medicine in New York, New York. Dr. Naidoo is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Hepato-Pancreato-Biliary Surgery, and Tissue Biopsy.

Andreas Rimner is a Radiation Oncologist practicing medicine in New York, New York. Dr. Rimner is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Tissue Biopsy, and Thymectomy.

Naiyer Rizvi is an Oncologist practicing medicine in New York, New York. Dr. Rizvi is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery.

Matthew Hellmann is an Oncologist practicing medicine in New York, New York. Dr. Hellmann is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Valerie Rusch is a Thoracic Surgeon practicing medicine in New York, New York. Dr. Rusch is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Mesothelioma, Lung Cancer, Lung Adenocarcinoma, Tissue Biopsy, and Thymectomy.

Joshua Sabari is an Oncologist practicing medicine in New York, New York. Dr. Sabari is rated as an Elite provider by MediFind in the treatment of Lung Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Thrombectomy.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Elite provider by MediFind in the treatment of Lung Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.